Genmab — Januar 2022
-
Tak. Kan anbefale chatgruppen for "aktiesnakken" eller "debat-området", hvor der kan føres mere generelle indlæg, som ikke nødvendigvis rammer Genmab chatten spot on
-
Aktier/åbning: C25 helt i grønt - forsikringsselskaber slipper billigt
https://www.proinvestor.com/investornyt/773502/aktier-abning-c25-helt-i-gront-forsikringsselskaber-slipper-billigt -
Aktier/middag: C25-rutsjebaneturen fortsætter med biotek i topform
https://www.proinvestor.com/investornyt/773530/aktier-middag-c25-rutsjebaneturen-fortsaetter-med-biotek-i-topform -
Genmab/HC Wainwright: ADR-notering hæves til "køb" fra "neutral"
https://www.proinvestor.com/investornyt/773555/genmab-hc-wainwright-adr-notering-haeves-til-kob-fra-neutral -
-
Daratumumab for treatment-refractory antibody-mediated diseases in neurology https://onlinelibrary.wiley.com/doi/10.1111/ene.15266
-
i said last week InnovaTV 205 was already combining with Keytruda , but not Keytruda and chemo together; they now add 1 arm to include that combo, possibly even a quad combination https://clinicaltrials.gov/ct2/history/NCT03786081?A=13&B=14&C=merged#StudyPageTop
-
Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Bispecific Antibody Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma https://www.businesswire.com/news/home/20220128005418/en/Janssen-Submits-Marketing-Authorisation-Application-to-the-European-Medicines-Agency-Seeking-Approval-of-Bispecific-Antibody-Teclistamab-for-the-Treatment-of-Patients-with-Relapsed-or-Refractory-Multiple-Myeloma
-
Genmab ligger sørme på 5. pladsen over de største skatteydere i 2021 https://finans.dk/erhverv/ECE13690430/her-er-danmarks-stoerste-skatteydere/?ctxref=ext
-
Mandagens aktier: C25 badet i grønt med biotek og Vestas i front
https://www.proinvestor.com/investornyt/773760/mandagens-aktier-c25-badet-i-gront-med-biotek-og-vestas-i-front -
Overraskende stille herinde i forhold til at ADS’en er 120kr over fredagens DK luk
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind